Posted on December 7, 2009 by Sitemaster
There continues to be controversy over the role of testosterone replacement therapy (TRT) in men with prostate cancer who are “hypogonadal” — i.e., men with very low testosterone levels — as a consequence of their treatment. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: testosterone replacement, TRT | 1 Comment »
Posted on April 18, 2009 by Sitemaster
Today’s news reports deal with:
- Active surveillance management strategies and outcomes to date
- Life expectancy and the appropriateness of treatment
- Penile rehabilitation post-surgery
- Testosterone replacement therapy in prostate cancer patients … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: active surveillance, life expectancy, penile rehabilitation, testosterone replacement, Treatment, TRT | Leave a comment »
Posted on March 10, 2009 by Sitemaster
Today’s news reports include items on:
- Risk for prostate cancer
- Patient decisions about sexual functionality and prostate cancer treatment
- Whole gland and focal cryotherapy
- Testosterone replacement after prostate cancer therapy
and other items. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: cryotherapy, decision process, focal, patient, risk, sexual function, testosterone replacement, Trelstar, TRT, UroCool™ | Leave a comment »
Posted on February 11, 2009 by Sitemaster
Today’s news reports contain four key items:
- A review of the potential of phytochemicals in treatment of prostate cancer
- A Norwegian study on correlation between biopsy-based and post-surgical Gleason scores
- A retrospective study on risk for prostate cancer in men being treated with testosterone replacement therapy
- An announcement of new data on PSP94 in the diagnosis of prostate cancer … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, Gleason score, Miraculins, phytochemicals, PSP94, testosterone replacement, TRT | Leave a comment »
Posted on November 2, 2008 by Sitemaster
In a separate post we have addressed the clinical significance of a finding of tertiary Gleason pattern 5 in a core (or cores) following prostate needle biopsy. Other reports, addressed below, deal with:
- Genomic markers for prostate cancer risk stratification
- Outcomes of men with “prevalent” as opposed to “incident” prostate cancer
- Quality of life of men diagnosed with and treated for T3-4 disease
- Testosterone replacement therapy and risk for prostatic disease … READ MORE …
Filed under: Uncategorized | Tagged: genomic biomarkers, incident, prevalent, quality of life, testosterone replacement | Leave a comment »
Posted on October 30, 2008 by Sitemaster
There’s a lot of news today, so we will break it into two sections for reading convenience. In Part A, we deal with information about:
- Physicial activity and prostate cancer risk
- Vasectomy and prostate cancer risk
- The use of surveillance and watchful waiting in men in Sweden
- A modification to Walsh’s nerve-sparing radical prostatectomy
- The risks of “multimodal” therapy in high-risk patients and
- A new, long-acting form of testosterone therapy … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Prevention, Treatment, Uncategorized | Tagged: Add new tag, multimodal therapy, physical activity, radical prostatectomy, risk, surveillance, testosterone replacement, vasectomy | Leave a comment »